User profiles for Trish M. Perl

Trish M. Perl, MD, MSc

Professor of Medicine and Chief of Infectious Diseases and Geographic Medicine …
Verified email at UTSouthwestern.edu
Cited by 54281
[PDF] academia.edu

Botulinum toxin as a biological weapon: medical and public health management

…, MT Osterholm, T O'Toole, G Parker, TM Perl… - Jama, 2001 - jamanetwork.com
ObjectiveThe Working Group on Civilian Biodefense has developed consensus-based
recommendations for measures to be taken by medical and public health professionals if …
Save Cite Cited by 2158 Related articles All 20 versions Library Search
[PDF] cdc.gov

Tularemia as a biological weapon: medical and public health management

…, MT Osterholm, T O'Toole, G Parker, TM Perl… - Jama, 2001 - jamanetwork.com
ObjectiveThe Working Group on Civilian Biodefense has developed consensus-based
recommendations for measures to be taken by medical and public health professionals if …
Save Cite Cited by 1808 Related articles All 20 versions Library Search
[PDF] oup.com

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection …

…, G Papanicolaou, TF Patterson, TM Perl… - Clinical infectious …, 2010 - academic.oup.com
Background. The incidence and epidemiology of invasive fungal infections (IFIs), a leading
cause of death among hematopoeitic stem cell transplant (HSCT) recipients, are derived …
Save Cite Cited by 1620 Related articles All 25 versions
[PDF] umich.edu

Clinical practice guidelines for antimicrobial prophylaxis in surgery

DW Bratzler, EP Dellinger, KM Olsen, TM Perl… - Surgical …, 2013 - liebertpub.com
Infectious Diseases Society of America (IDSA), the Surgical Infection Society (SIS), and the
Society for Healthcare Epidemiology of America (SHEA). This work represents an update to …
Save Cite Cited by 3435 Related articles All 46 versions
[HTML] oup.com

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)

…, BJ Park, TF Patterson, TM Perl… - Clinical Infectious …, 2010 - academic.oup.com
Background. Invasive fungal infections (IFIs) are a major cause of morbidity and mortality
among organ transplant recipients. Multicenter prospective surveillance data to determine …
Save Cite Cited by 1595 Related articles All 25 versions
[HTML] nejm.org

[HTML][HTML] Hospital outbreak of Middle East respiratory syndrome coronavirus

A Assiri, A McGeer, TM Perl, CS Price… - … England Journal of …, 2013 - Mass Medical Soc
Background In September 2012, the World Health Organization reported the first cases of
pneumonia caused by the novel Middle East respiratory syndrome coronavirus (MERS-CoV). …
Save Cite Cited by 1528 Related articles All 16 versions
[PDF] cdc.gov

Anthrax as a biological weapon, 2002: updated recommendations for management

…, J McDade, MT Osterholm, G Parker, TM Perl… - Jama, 2002 - jamanetwork.com
ObjectiveTo review and update consensus-based recommendations for medical and public
health professionals following a Bacillus anthracis attack against a civilian population.…
Save Cite Cited by 1387 Related articles All 19 versions Library Search
[HTML] oup.com

Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options

…, LL Maragakis, TM Perl - Clinical infectious …, 2008 - academic.oup.com
Multidrug-resistant Acinetobacter baumannii is recognized to be among the most difficult
antimicrobial-resistant gram-negative bacilli to control and treat. Increasing antimicrobial …
Save Cite Cited by 1527 Related articles All 16 versions

Plague as a biological weapon: medical and public health management

…, G Parker, TM Perl, PK Russell, M Schoch-Spana… - Jama, 2000 - jamanetwork.com
ObjectiveThe Working Group on Civilian Biodefense has developed consensus-based
recommendations for measures to be taken by medical and public health professionals following …
Save Cite Cited by 1291 Related articles All 15 versions

Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter …

…, RE Crowell, SQ Simpson, M Neidhart, M Dunn… - Jama, 1995 - jamanetwork.com
Objective. —To evaluate the efficacy and safety of anti—tumor necrosis factor α monoclonal
antibody (TNF-α MAb) in the treatment of patients with sepsis syndrome. Design. —…
Save Cite Cited by 1211 Related articles All 10 versions